
    
      Participants who provide informed consent and are determined to be eligible will then
      participate in the study.

      A total of 160 patients with obesity and regular LOC-eating following MBS will be randomly
      assigned (double-blind) in a balanced factorial (2 X 2) design, to one of four 16-week
      interventions: BWL+NB, BWL+Placebo, NB, or Placebo. The randomization will be in equal
      proportions but stratified by surgery type.
    
  